DUBLIN--(BUSINESS WIRE)--The "IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering Technology, Application - Global Forecast to 2031" report has been added to ...
In vitro diagnostics (IVD) assay development services provide comprehensive, end-to-end contracting solutions. These services include assay design and proof of concept, feasibility studies, prototype ...
Zacks Investment Research on MSN
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD
RNA sequencing provides a comprehensive view of biological information, offering deeper insights into disease mechanisms, including improved fusion detection. As a powerful tool in research and ...
A European CDMO dedicated to In Vitro Diagnostics Helio Diagnostics is backed by a team with 25+ years of experience in the ...
Register for our upcoming webinar “Accelerate your IVD assay development with the unique support of the Dynabeads team” and learn how Dynabeads technology and commercial partnership can help ...
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration ...
IVD devices enable earlier breast cancer diagnoses than mammograms, and detect genetic abnormalities that can contribute to ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback